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Fine-Needle Aspiration Biopsy
Its Use in Orbital Tumors
John S. Kennerdell, MD; Andrew Dekker, MD; Bruce L. Johnson, MD; Philip J. Dubois, MD
\s=b\Fifteen orbital tumors have been eval-
uated with the fine-needle aspiration biop-
sy (FNAB) technique. The best indication
for FNAB is supposed malignant orbital
disease. The technique has not been
helpful in tumors or inflammatory disease
with a high fibrous content. Lesions that
are suspected of being pseudotumors are
not recommended for FNAB since, even in
histologic sections, they are notoriously
difficult to distinguish from well-differen-
tiated lymphocytic malignant lymphoma.
Benign encapsulated tumors should not
be subjected to FNAB.
(Arch Ophthalmol 97:1315-1317, 1979)
Interest has increased in the use of
fine-needle aspiration biopsy(FNAB) techniques to diagnose neo¬
plasms from a variety of different
organs, ie, thyroid gland, lymph
nodes, salivary gland, lung, pancreas,
prostatic gland, and deep abdominal
areas.11" Although experience with
FNAB and orbital tumors appeared in
the literature in 1975 as an abstract
from Sweden,1112 to our knowledge,
there have been no other reports of its
use in the orbit. During an 18-month
period, we have used the FNAB tech¬
nique in 15 patients with various or¬
bital lesions. In seven of these
patients, positive results were ob¬
tained, and subsequent events con¬
firmed the presence of a neoplasm.
The best use of FNAB appears to be
in establishing a diagnosis of a malig¬
nant unresectable orbital neoplasm,
thus eliminating a need for further
surgical intervention.
METHODS
The method of the needle aspiration
biopsy technique, as described by Einhorn
and Franzen,4 consists of the use of a No.
22- or 23-gauge, thin, disposable needle
attached to a 20-mL syringe, which is in
turn attached to a pistol-type syringe hold¬
er (Fig 1). With this equipment, the sur¬
geon can obtain strong aspiration pressure
with one hand.
The needle that is attached to this unit is
introduced into the orbital mass without
application of aspiration pressure. While
suction is applied, the needle is moved back
and forth and angled in different planes of
the tumor. Aspiration pressure is released
before the needle is removed from the
mass. The whole procedure takes less than
a minute.
The cytologist/pathologist or cytotech-
nologist, who is present at the time of the
procedure, either in the office or in the
operating room, prepares the cytologie
specimens. These slides are quickly fixed in
95% alcohol and stained according to the
Papanicolaou technique. In addition, any
material that is left in the aspirating
needle is removed and fixed for at least 20
minutes with 4% formaldehyde and then
submitted as a cell block. This material is
embedded in paraffin so that hematoxylin-
eosin ( -E) histologie sections can beprepared. The latter preparations, in addi¬
tion to giving added evidence for malig¬
nancy, are particularly suited for histologie
identification of tumor type.
If an immediate diagnosis is required,
the cytology preparations can be stained
with
 -E after fixation for a short period
with 95% alcohol.
Perfection of this technique depends on
consultation, close cooperation, and inter¬
est of the ophthalmologist, cytologist/
pathologist, and ophthalmic pathologist.
RESULTS
The Table summarizes our experi¬
ence in 15 cases in which the FNAB
technique was used. Positive results
were obtained in two patients with
metastatic orbital tumors; one had an
unresectable malignant orbital tumor,
one had direct extension of carcinoma
from the ethmoid sinus, and one had
adenoidcystic from the lacrimal gland.
Positive results were also obtained in
a patient with a malignant glioma of
the optic nerve that was subsequently
confirmed by an incisional biopsy
specimen and in a patient with a
primary orbital meningioma. The val¬
ue of the FNAB technique in the
identification and management of
patients with malignant orbital tu¬
mors can best be illustrated in the
following specific cases.
REPORT OF CASES
Case 1.—A 77-year-old man had a 6-mm
right proptosis of three months' duration
without other symptoms except a 9.1-kg
weight loss in the past six months. A
coronal computerized tomographic (CT)
scan demonstrated an abnormality in the
roof of the right orbit adjacent to bone but
was otherwise normal. His age, weight loss,
CT scan abnormality, and proptosis strong¬
ly suggested metastatic disease. Systemic
investigation disclosed that he had prostat-
ic carcinoma, which was proved by a biopsy
specimen. The cytologie FNAB specimen
from the upper orbit was thought to be
positive for malignant cells (Fig 2 and 3),
which correlated well morphologically with
prostatic carcinoma (Fig 4). Since undergo¬
ing an orehiectomy, he has had a 3-mm
reduction in the right proptosis.
Case 2.—A 63-year-old man had progres¬
sive vision loss to no light perception (NLP)
in the right eye during a two-month period.
Four months later, visual loss in the left
eye began in the temporal field andprogressed rapidly to include fixation.
Visual acuity was NLP in the right eye and
6/12 in the left eye. The visual field showed
an upper temporal depression in the left
eye. There was a 3-mm right proptosis with
chemosis of the conjunctiva and loss of
lateral rotation. The right fundus showed a
diffuse hemorrhage pattern with a sharp
elevation of the optic disc that was sugges¬
tive of a malignant optic nerve tumor."
The left fundus was normal.
An ultrasonogram showed an enlarged
optic nerve shadow behind the globe, and
the CT scan showed diffuse enlargement of
the optic nerve with an intracranial exten¬
sion in the prechiasmatic cistern of a
tumor mass. The aspiration biopsy tech¬
nique was done under CT scan control of
the right optic nerve tumor. A No. 22-
gauge thin needle was introduced in the
usual retrobulbar fashion through the
lateral lower lid, and the position of the tip
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of the needle was assessed by CT scan
when it was thought to be located properly
in the optic nerve tumor.14 When the coro¬
nal and basilar CT scans confirmed that
the needle was in the optic nerve, the
syringe and pistol grip were attached, and
the aspiration biopsy specimen was taken.
Cytologie aspirate showed malignant cells,
consistent with astrocytes. The needle
biopsy diagnosis was confirmed by an
anterior medial microorbitotomy." A
craniotomy was averted in this malignant
gliomatous process. Radiation therapy re-
suited in a temporary improvement of
vision of the left eye, which had rather
rapidly deteriorated to 6/30 back to a level
of about 6/9.
COMMENT
First described by Martin and
Ellis'" in 1930, the FNAB technique
has not been popular in the United
States due to understandable reluc¬
tance, bred by unfamiliarity, of both
surgeons and pathologists. In Scandi-
navian countries, it has gained accept¬
ance during the past two decades and
more recently has been used in the
United States to identify malignant
tumors in various areas of the
body.1-"· Two Scandinavian articles
have pointed to its potential in the
orbit.11-12
A combination of relative loss of
cohesion of neoplastic cells and strong
suction allows aspiration of cells by
the FNAB technique. The diagnosis of
Fig 1.—Syringe pistol with 20-mL plastic disposable syringe and
No. 22-gauge, 3.8-cm, disposable needle attached.
Fig 2.—Fine-needle aspiration biopsy preparation (case 1).
Groups of cells with high nuclear-cytoplasmic ratio and occasion¬
al prominent irregular nucleoli are diagnostic of malignant
process (Papanicolaou stain,  788).
Fifteen Cases With Use of Fine-Needle Aspiration Biopsy Technique
Case/
Age, yr Clinical Summary* Cytologie Finding Histologie Diagnosist
1/77 Case 1 in text Adenocarcinoma Adenocarcinoma (prostatic biopsy)
2/63 Case 2 in text Highly suspicious for malignant as-
trocytoma; atypical astrocytes, in¬
cluding mitotic figures
Malignant glioma of optic nerve
3/63 Progressive right proptosis with visual loss and
frozen globe followed by rapid extension of
mass from orbit to preauricular area
Carcinoma Not performed
4/24 Progressive vision loss OD to bare LP causing
right optic atrophy with shunt vessel; posterior
enlarged optic nerve seen on CT scan
Meningloma (whorls of meningothe-
lial cells)
Not performed
5/21 Acute left proptosis with frozen globe; undifferen-
tlated carcinoma in left parotid gland area pre¬
viously diagnosed
Carcinoma Undifferentiated carcinoma
6/27 Large ethmoid mass extending into both orbits
with predominantly left proptosis for 3 mo
Carcinoma Poorly differentiated adenoidcystic car¬
cinoma of the ethmoid sinus
7/23 Rapid left proptosis with no functional deficit;
large mass in lateral orbit extending into tempo¬
ral and middle cranial fossa on CT scan
Carcinoma Adenoidcystic carcinoma of lacrimal
gland
8/50 Right superior anterior orbital mass causing ptosis
and vertical diplopia for 1 mo
Mature lymphocytes Lymphoid hyperplasia (lymphoid
pseudotumor)
9/67 Left superior anterior orbital mass causing ptosis,
proptosis, mild pain, and blurred vision for 6 mo
Mature lymphocytes Lymphoid hyperplasia (lymphoid
pseudotumor)
10/7 Left posterior medial orbital mass causing ptosis,
proptosis, and upgaze limitation for 2 mo
No identifiable cells obtained Inflammatory pseudotumor with reac¬
tive fibrosis
11/31 Mass in left inferior anterior orbit for 1 mo; subse¬
quent pulmonary sarcoid discovered
Fibrous connective tissue Granulomatous inflammation consistent
with sarcoid
12/26 Left lacrimai mass for 6 yr that enlarged slowly Mature lymphocytes Benign lymphoepithelial lesion of God¬
win, lacrimal gland




14/31 Left lateral orbital mass since childhood with re¬
cent enlargement
Keratin debris and hair shafts Dermoid cyst
15/50 Lymphosarcoma for 7 yr; mass in right inferior an- Erythrocytes
terior orbit noted for 1 mo
Cavernous hemangioma
*LP indicates light perception; CT, computerized tomography.
fDiagnosis was confirmed by results of incisional or excisional biopsy.
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Fig 3.—Cell block preparation (case 1). Note occasional acinar
grouping of cells indicating adenocarcinoma (hematoxylin-eosin,
 788).
Fig 4.—Biopsy specimen from prostate gland with neoplastic cells
infiltrating muscle bundles (case 1). Note resemblance of cells to
those seen in Fig 3 (hematoxylin-eosin,  788).
malignancy depends on the presence
of so-called malignant criteria in cells,
such as an altered nuclear-cytoplasmic
ratio, irregularity and clumping of
chromatin, and abnormality of nu¬
cleoli. These are identical to the crite¬
ria used in standard exfoliative cytolo¬
gy. Since identification of the tumor
type guides eventual therapy, an
effort is always made to determine
this. The appearance of the cytoplasm
and grouping of cells in relation to
each other in the cell block is helpful in
this regard (Fig 3). However, the
FNAB is a cytologie technique where
extent of invasion cannot be deter¬
mined, as it can in histologie prepara¬
tions, though this does not make it any
less accurate.
The FNAB has been most helpful in
identifying malignant epithelial tu¬
mors, suspicion of which is the main
indication for its use in the orbit. Case
2, however, indicates that nonepithe-
lial malignant tumors can also be
diagnosed with this technique.
The FNAB plays a lesser role in
evaluation of pseudotumors. This di¬
agnosis cannot be made by cytologie
criteria alone, but depends primarily
on histologie architecture, in conjunc¬
tion with cytologie features, in appro-
priately prepared  -E histologie sec¬
tions. Although malignant lymphoma
was not seen in this study, we antici¬
pate that the diagnosis could easily be
made by this method, especially in the
poorly differentiated lymphocytic or
histiocytic varieties, since we have
detected them in other sites previous¬
ly. The negative results of some of the
biopsies, not unexpectedly, have been
from tumors with a predominantly
fibrous matrix where cohesion is
strong and cellularity diminished or
from cystic masses.
Tumors of a well-circumscribed
type, thought to be benign, should not
be subjected to needle biopsy. This is
especially true in the case of benign
mixed lacrimal tumor or hemangio-
pericytoma where capsule violation
might alter the nature of the tumor to
a more aggressive locally infiltrative
behavior. The physician should always
be aware of sampling problems that
might arise with this technique and
recognize that a negative report
should not preclude the use of other
methods to confirm a strong clinical
impression.
Secondary carcinoma that involves
the orbit, either by direct extension
from an adjacent structure or as a
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